MorphoSys Constellation Acquisition Royalty Pharma Partnership 2021

MorphoSys announced its acquisition of Constellation Pharmaceuticals with strategic funding partnership support from Royalty Pharma plc. The transaction includes advancement of Constellation's clinical pipeline including pelabresib and other candidates. Call details executive presentations on R&D integration and financial strategy.